Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Turk J Med Sci ; 54(1): 194-203, 2024.
Article in English | MEDLINE | ID: mdl-38812639

ABSTRACT

Background/aim: Nocturnal enuresis can be frustrating for children and their families as the child ages. Our aim is to evaluate urine aquaporin 2 (AQP-2) as a noninvasive biomarker of water balance in children with primary monosymptomatic nocturnal enuresis (PMNE). Material and methods: The study included 90 children; sixty-eight children suffering from PMNE aged (9.57 ± 2.16) years and 22 healthy children with good toilet control, matched sex and age. All enuretic children were subjected to complete history taking, clinical evaluation, and bed wetting diary. Serum arginine vasopressin (AVP) and urine AQP-2 were tested in the morning (at 9-11 am) and evening (at 9-11 pm). Blood urea, creatinine, Na, glucose, urine osmolality, Ca/Cr, Alb/Cr and specific gravity were tested simultaneously. Results: Serum AVP, urine AQP-2, and urine osmolality were statistically lower in patients than controls. Patients had a significantly lower level of night serum AVP concentrations, urine AQP-2, and urine osmolality than the corresponding morning level. Urine AQP-2 was significantly correlated with urine osmolality (p < 0.05). AQP-2 had a sensitivity of 90% and a specificity of 70%. However, no statistically significant correlation was found between serum AVP and urine AQP-2. Conclusion: Primary monosymptomatic nocturnal enuresis in children could be associated with reduction of urine excretion of AQP-2 at night. Urine AQP-2 is significantly correlated with urine osmolality. Therefore, it may be a noninvasive biomarker of hydration status in children with PMNE, with good sensitivity and specificity.


Subject(s)
Aquaporin 2 , Biomarkers , Circadian Rhythm , Nocturnal Enuresis , Humans , Child , Nocturnal Enuresis/urine , Nocturnal Enuresis/blood , Male , Female , Aquaporin 2/urine , Circadian Rhythm/physiology , Biomarkers/urine , Biomarkers/blood , Osmolar Concentration , Case-Control Studies , Arginine Vasopressin/blood , Arginine Vasopressin/urine , Adolescent
2.
Rheumatol Int ; 40(10): 1599-1611, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32710198

ABSTRACT

The aim of this work is to trace how rheumatologists all over Egypt are approaching the COVID-19 pandemic and what changes it has brought about in the patients' care with special attention to its effect on vulnerable rheumatic disease (RD) patients. This survey further aims to help inform the rheumatology community about the changes in practice during the COVID-19 pandemic. The survey included 26 questions distributed to University staff members across Egypt members of the Egyptian College of Rheumatology (ECR). It takes 5-10 min to fill out. The practice setting of participating rheumatologists included University Teaching Hospitals that are the main rheumatology and clinical immunology service providers for adults and children RD patients. There was an overall agreement across the country in the responses to the survey that took a median time of 7 min to fill in. Potential changes in rheumatology outpatient practice by staff members evolved since the COVID-19 pandemic. None of the university rheumatology staff members has prescribed chloroquine or HCQ to prevent or treat COVID-19 in a non-hospitalized patient who was not previously on it. Twenty-three recommended decrease/avoid NSAIDs if the RD patient had confirmed COVID-19 or symptoms. There is an agreement to the key emerging frontline role of rheumatologists in treating COVID-19. During the pandemic, RD cases requiring admission were dealt with by several modified strategies. The overall agreement among the different university rheumatology departments during such critical situation has provoked the ECR to consider providing provisional guidelines for dealing with RD patients during this global catastrophe.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antirheumatic Agents/therapeutic use , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Practice Patterns, Physicians'/statistics & numerical data , Rheumatic Diseases/drug therapy , Rheumatologists/statistics & numerical data , Ambulatory Care/statistics & numerical data , Antirheumatic Agents/supply & distribution , Betacoronavirus , COVID-19 , Coronavirus Infections/drug therapy , Coronavirus Infections/prevention & control , Deprescriptions , Egypt/epidemiology , Humans , Hydroxychloroquine/supply & distribution , Hydroxychloroquine/therapeutic use , Pandemics/prevention & control , Pneumonia, Viral/drug therapy , Pneumonia, Viral/prevention & control , Rheumatology , SARS-CoV-2 , Surveys and Questionnaires , COVID-19 Drug Treatment
3.
Arch Gerontol Geriatr ; 81: 8-17, 2019.
Article in English | MEDLINE | ID: mdl-30471472

ABSTRACT

PURPOSE: The study was done to investigate whether a postoperative intervention program is effective in reducing mortality and improving mobility in two comparative hip fracture patients over one year postoperatively. METHODS: A non-randomized controlled trial study with an intervention group of hip fracture patients and historical control group with 12 months follow up. One hundred twenty four admitted hip fracture patients to the Trauma Unit of Assiut University Hospitals, aged 50 years and older were included from 1st July to 31st December 2014. They were divided into 64 and 60 patients as intervention and control groups respectively. Weight, height and bone mineral density were measured and baseline characteristics were taken. The intervention was a postoperative care program in the form of education sessions with an explanatory leaflet on discharge for nutrition and physical exercise program at home. Follow up phone calls were done at 3 months, 6 months and one year postoperatively by one assessor. Physical mobility was assessed by 24 items Western Ontario And McMaster Universities Osteoarthritis Index (WOMAC). RESULTS: Mortality was significantly higher in the control group, WOMAC score was significantly better among intervention group through follow up. By multivariate Cox survival analysis, advancing age, no intervention, osteoporosis, postoperative complications, chest infections and heart attacks were significant predictors for mortality. CONCLUSION: A significant improvement in mobility and reduction of mortality was achieved by application of a postoperative care program that could be incorporated into the hip fracture patients' care pathway.


Subject(s)
Exercise Therapy , Hip Fractures/mortality , Hip Fractures/surgery , Nutrition Therapy , Self Care , Age Factors , Aged , Aged, 80 and over , Counseling , Female , Historically Controlled Study , Humans , Male , Malnutrition/prevention & control , Middle Aged , Multivariate Analysis , Myocardial Infarction/epidemiology , Osteoporosis/epidemiology , Patient Education as Topic , Postoperative Care , Postoperative Complications/epidemiology , Prospective Studies
5.
J Clin Lipidol ; 4(3): 185-95, 2010.
Article in English | MEDLINE | ID: mdl-21122651

ABSTRACT

BACKGROUND: The prevalence and magnitude of childhood obesity are increasing dramatically. OBJECTIVES: To examine the effect of varying social, demographic, dietary, and activity factors on the prevalence of metabolic syndrome and its relation to insulin resistance, C-reactive protein, and homocysteine levels in a large, representative sample of Egyptian adolescents. METHODS: Our survey included 4250 adolescents (from 10 to 18 years of age; male subjects comprised 42.5% of participants) from 7 governorates representing Egypt. Baseline measurements included blood pressure, fasting blood glucose, plasma lipids, C-reactive protein, and homocysteine levels. Because the body mass index varies according to age, we standardized the value for age and sex with the use of conversion to percentiles. RESULTS: The overall prevalence of the metabolic syndrome was 7.4% with no sex or area of residence predilection. Results showed that adolescents with the full criteria of metabolic syndrome (ie, three criterion or more) constituted nearly one fourth of those exhibiting high values of different components, except for systolic blood pressure, where they were 42%, and TG, where they were 31%. Family history of obesity and diabetes mellitus increase the odds for metabolic syndrome significantly (1.68 and 1.3, respectively) as well as inactivity. A high level of C-reactive protein was reported among affected adolescents. Homocysteine level did not have an influence. CONCLUSIONS: The prevalence of the metabolic syndrome is considerable among obese adolescents. Proinflammatory markers associated with an increased risk of adverse cardiovascular outcomes are already present in these youth.


Subject(s)
Insulin Resistance , Metabolic Syndrome/epidemiology , Adolescent , Blood Glucose/metabolism , Blood Pressure , C-Reactive Protein/metabolism , Child , Egypt/epidemiology , Female , Homocysteine/blood , Humans , Hypertension/complications , Male , Metabolic Syndrome/blood , Metabolic Syndrome/etiology , Obesity/complications , Prevalence , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...